Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy

Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy

US Patent 11116834 · Granted Sep 14, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of triplex CMV vaccine in CAR T cell therapy2025
Targeted chimeric antigen receptor modified T cells for treatment of IL13Rα2 pos2025
Activatable masked anti-CTLA4 binding proteins2025
Anti-CD6 antibody-growth factor complex for treating autoimmune diseases2025
Genetically stable recombinant modified vaccinia Ankara (RMVA) vaccines and meth2025
CD6 targeted chimeric antigen receptors for treatment of certain autoimmune diso2025
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy2024
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy2024
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy2024
MVA vaccine for delivery of a UL128 complex and preventing CMV infection2024
T cells for expression of chimeric antigen receptors and other receptors2024
Multi-specific ligand binders2024